about
P6185
Reversibility of fenofibrate therapy-induced renal function impairment in ACCORD type 2 diabetic participants.Physical and clinical pathological findings associated with experimentally induced rupture of the equine urinary bladderImproved estimation of glomerular filtration rate (GFR) by comparison of eGFRcystatin C and eGFRcreatinine.Proximal tubular secretion of creatinine by organic cation transporter OCT2 in cancer patients.Comparing cystatin C and creatinine in the diagnosis of pediatric acute renal allograft dysfunctionInterdialytic creatinine change versus predialysis creatinine as indicators of nutritional status in maintenance hemodialysis.A role for the organic anion transporter OAT3 in renal creatinine secretion in mice.Characterization of urinary biomarkers of hepatocellular carcinoma using magnetic resonance spectroscopy in a Nigerian population.Evaluation of the efficacy and safety of conversion to sirolimus in 85 renal transplant recipients.Additional beneficial effects of canrenoate in patients with anterior myocardial infarction on ACE-inhibitor treatment. A pilot study.Lack of renoprotective effect of theophylline during aortocoronary bypass surgery.Application of creatinine-sensitive biosensor for hemodialysis control.Relationship between normal serum creatinine concentration and periodontal disease in Japanese middle-aged males.Synthesis of an imprinted hybrid organic-inorganic polymeric sol-gel matrix toward the specific binding and isotherm kinetics investigation of creatinine.[Effect of losartan on the expressions of TGF-beta1, p-Smad2/3, and Smad7 in the remnant renal tissues of 5/6 nephrectomized rats].An analysis of measured and estimated creatinine clearance rates in normal weight, overweight, and obese patients with gynecologic cancers.A metabolomic comparison of urinary changes in type 2 diabetes in mouse, rat, and humanSpuriously raised serum creatinine associated with an excipient present in an intravenous dexamethasone formulationA novel structural specific creatinine sensing scheme for the determination of the urine creatinineComparison of serum creatinine and cystatin C for early diagnosis of contrast-induced nephropathy after coronary angiography and interventionsEvaluation of the performance of urine albumin, creatinine and albumin-creatinine ratio assay on two POCT analyzers relative to a central laboratory methodUrinary protein/creatinine ratio versus 24-hour proteinuria in the evaluation of lupus nephritisMonodispersed molecularly imprinted polymer for creatinine by modified precipitation polymerization
P921
Q14907629-A6FAEE1B-7021-45B6-B624-2AC330C531FEQ21106412-8D5D5774-8D2D-41E8-A006-0EDE82300EE2Q22275993-BE61CA7E-933A-41B8-962F-E5A533BF5CADQ22275994-F20E080C-6D08-48AD-8F1A-0F0D607FFF2AQ22298140-3CB225D4-C6E1-416E-961C-0B7AD220CFD7Q28031281-33F5C97B-4C3E-435D-B5A9-E244366E726AQ30225376-595A604E-E898-4A93-9CF8-73FA6FF1408B
P527
Q30419512-A91D17F4-8C8B-40DE-AE87-796BDE22C1B5Q35191826-73D49B0A-B054-49D8-9AEF-C3A53A0381A1Q35755932-A5ECF86C-EF9B-4516-8E83-81D666AEEDD2Q35783532-D65C1C93-5582-4E12-800C-3476C8B2AE1AQ35861355-03D77CBD-4669-40AC-9389-0B4388697207Q35953259-7F0791AB-704C-4B40-A958-03C1DE2BB378Q35993954-9BA71AA9-D194-4574-A478-7F8FC6477EE2Q43228011-7C722EC0-A31A-4F44-9003-5572180A8658Q43284031-1E45401D-A780-4338-AF76-397BAF074DB4Q43546437-E4477BBA-8044-43F3-880E-FB43CB123638Q43974318-56ECD478-B2CC-4DAF-8361-1C9CB862E5D6Q43989051-A585A425-F5D6-4CCA-A487-E9CA3AB4344BQ44525613-EF213A8F-F7D9-4ABD-B57D-F5D76399170DQ46012305-5550649E-4433-4F06-A8C6-DAB50B376793Q46817181-2BD70156-CED4-4297-8C8C-C8C0F78CB34BQ47326692-5D7E7EED-CE19-4652-87DC-66729F1A1C84Q57016081-CBB00510-9714-4797-BE5C-205EFDE6EBAAQ63367747-0D7AD681-01FB-4262-BB46-E67DA1E07C9EQ82312525-AF9A93A2-641C-4D5E-ABCC-B00E2174E07CQ82937922-1F97E06F-852A-412B-84D0-50C8087C1E26Q83164041-93AF96CB-ED1C-4BED-8C28-211EBB81095DQ83730610-91E9211D-B4A9-4C2F-859A-F2F242E9BDDDQ83876531-59E235FC-DD4A-416C-A8E5-C1771CB06937
P921
description
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
creatinine tautomer
@en
type
label
creatinine tautomer
@en
altLabel
2-amino-3-methyl-4H-imidazol-5-one
@en
prefLabel
creatinine tautomer
@en
P361
P4964
P6689
P662
P683
P231
P233
CN1CC(=O)NC1=N
P234
1S/C4H7N3O/c1-7-2-3(8)6-4(7)5/h2H2,1H3,(H2,5,6,8)
P235
DDRJAANPRJIHGJ-UHFFFAOYSA-N
P274
P3117
DTXSID8045987
P361
P4964
splash10-0002-9000000000-eeae0d044f851730b29a
splash10-0006-9000000000-1498f1dfaa82105e4414
splash10-0006-9000000000-445863d7d688052704e5
splash10-0006-9000000000-bfa35af1a437cbc8b5ec
splash10-0006-9000000000-d29412c66299b75ddaf3
splash10-0006-9000000000-e1a13a6d6f6297658faf
splash10-0006-9000000000-e79b269b74d9c6e99118
splash10-0006-9000000000-eb980aaa3180c2912a91
splash10-0006-9000000000-f87b49f5a20f18c9f6f3
splash10-0006-9000000000-fc6ec4c9a4d78532313c